T1	PROC 44 69	Seguimiento a largo plazo
T2	Date 56 69	a largo plazo
T3	LIVB 73 82	pacientes
#1	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	DISO 87 111	atrofia muscular espinal
#2	AnnotatorNotes T4	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T5	PROC 112 120	tratados
T6	PROC 124 140	ensayos clínicos
#3	AnnotatorNotes T6	C0008976; Clinical Trials; Research Activity
T7	CHEM 145 151	OAV101
T8	PROC 172 197	Seguimiento a largo plazo
T9	Date 184 197	a largo plazo
T10	LIVB 201 210	pacientes
#4	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 215 239	atrofia muscular espinal
#5	AnnotatorNotes T11	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T12	PROC 240 248	tratados
T13	PROC 252 268	ensayos clínicos
#6	AnnotatorNotes T13	C0008976; Clinical Trials; Research Activity
T14	CHEM 273 279	OAV101
T15	Route 293 295	IV
T16	DISO 309 333	atrofia muscular espinal
#7	AnnotatorNotes T16	C0026847; Spinal Muscular Atrophy; Disease or Syndrome
T17	LIVB 364 377	participantes
T18	PROC 496 510	ensayo clínico
#8	AnnotatorNotes T18	C0008976; Clinical Trials; Research Activity
T19	CHEM 515 521	OAV101
T20	PROC 541 577	consentimiento informado por escrito
T22	LIVB 669 677	paciente
#10	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	LIVB 678 690	progenitores
#11	AnnotatorNotes T23	C0030551; parent; Family Group | C0870134; Ancestor; Family Group
T24	LIVB 691 702	tutor legal
T26	Neg_cue 789 798	carece de
T27	Negated 799 821	criterios de exclusión
T28	Date 12 16	2021
T29	Route 288 290	IT
T21	PROC 612 634	evaluación del estudio
T25	PROC 724 750	procedimientos del estudio
